Vaccinating patients with autoimmune diseases

Area of Science:

• Rheumatology
• Immunology
• Infectious Diseases

Background:

• Patients with rheumatic diseases often have weakened immune systems due to their condition and treatments.
• This immunosuppression increases their susceptibility to vaccine-preventable diseases, particularly respiratory infections.

Purpose of the Study:

• To review optimal vaccination strategies for patients with rheumatic diseases.
• To focus on the efficacy and safety of recommended vaccines in this population.

Main Methods:

• Review of current literature on vaccine efficacy and safety in immunosuppressed patients.
• Analysis of factors influencing vaccine response in rheumatic disease patients.

Main Results:

• Vaccines are generally effective but may have reduced efficacy in immunosuppressed individuals.
• Withholding methotrexate temporarily post-vaccination may enhance immune response.
• Live vaccines pose challenges; assessing immunosuppression and following guidelines are key.
• Measles immunoglobulin is an alternative if vaccination is not feasible.

Conclusions:

• Vaccination is vital for reducing infection risk in rheumatic disease patients.
• High-dose prednisolone, B-cell depleting therapies, and methotrexate are associated with reduced vaccine responses.
• Vaccination timing should be considered when immunosuppression is least severe.